title: Upregulation of lipogenesis and protein tyrosine phosphatase-1B expression in the liver of Wistar rats with metabolic syndrome chronically induced by drinking sucrose water.
abstract: BACKGROUND
  Establishing animal models with metabolic disorders similar to human metabolic syndrome (MS) is important. In terms of eliciting a full array of MS, we have previously shown that Wistar rats are more responsive to sucrose water drinking than are C57BL/6J mice. This study was aimed at investigating the underlying molecular mechanism of sucrose water-induced MS in Wistar rats.
  
  
  METHODS
  Male Wistar rats were divided into 2 groups (n = 8 for each group) which were given plain water (C group) or 30% sucrose water (SW group) to drink ad libitum. After 20 weeks, the transcriptional levels and protein translocation of hepatic sterol regulatory element-binding protein-1c (SREBP-1c) and carbohydrate response element-binding protein (ChREBP) as well as the protein levels of protein tyrosine phosphatase-1B (PTP-1B) in insulin-responsive tissues (liver, muscle, and adipose tissue) were measured.
  
  
  RESULTS
  The sucrose water regimen successfully elicited visceral obesity, hypertriglyceridemia, insulin resistance, and high blood pressure. The upregulation of de novo lipogenesis in the liver of the sucrose water-treated rats was demonstrated by an increased activity of enzymes, mRNA levels of lipogenic proteins, and nuclear levels of SREBP-1c and ChREBP. Moreover, in the sucrose water-treated rats, protein levels of PTP-1B were significantly increased in liver and skeletal muscle but decreased in adipose tissue.
  
  
  CONCLUSIONS
  The susceptibility of Wistar rats to sucrose water-induced MS is associated with the transactivation of SREBP-1c and ChREBP in the liver, and PTP-1B is involved in the upregulation of de novo lipogenesis in the liver and the pathology of systemic insulin resistance in rats with MS chronically induced by drinking sucrose water.
authors.affiliation: Institute of Nutrition, China Medical University, Taichung, Taiwan, ROC.
authors.forename: Chun-Yin
authors.initials: CY
authors.lastname: Huang
authors.forename: Yu-Shun
authors.initials: YS
authors.lastname: Lin
authors.forename: Gou-Chun
authors.initials: GC
authors.lastname: Chen
authors.forename: Hui-Ling
authors.initials: HL
authors.lastname: Huang
authors.forename: Shu-Han
authors.initials: SH
authors.lastname: Chuang
authors.forename: Pei-Min
authors.initials: PM
authors.lastname: Chao
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D019422:Dietary Sucrose / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism; D004195:Disease Models, Animal; D005786:Gene Expression Regulation; D006801:Humans; D007333:Insulin Resistance; D050155:Lipogenesis / Q000235:genetics*; D008099:Liver / Q000378:metabolism*; D008297:Male; D024821:Metabolic Syndrome / Q000378:metabolism*; D017027:Protein Tyrosine Phosphatases / Q000378:metabolism*; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D051780:Sterol Regulatory Element Binding Protein 1 / Q000378:metabolism; D015854:Up-Regulation
chemical_list: D001786:Blood Glucose; D019422:Dietary Sucrose; D051780:Sterol Regulatory Element Binding Protein 1; D017027:Protein Tyrosine Phosphatases